Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities.

Abstract : Neutrophils play a major role in inflammation by releasing large amounts of reactive oxygen species (ROS) produced by NADPH oxidase (NOX) and myeloperoxidase (MPO). This ROS overproduction is mediated by phosphorylation of the NOX subunits in an uncontrolled manner. Therefore, targeting neutrophil subunits would represent a promising strategy to moderate NOX activity, lower ROS, and other inflammatory agents, such as cytokines and leukotrienes, produced by neutrophils. For this purpose, we investigated the effects of protectin DX (PDX)-a docosahexaenoic acid di-hydroxylated product which inhibits blood platelet aggregation-on neutrophil activation in vitro. We found that PDX decreases ROS production, inhibits NOX activation and MPO release from neutrophils. We also confirm, that PDX is an anti-aggregatory and anti-inflammatory agent by inhibiting both cyclooxygenase-1 and -2 (COX-1 and COX-2, E.C. 1.14.99.1) as well as COX-2 in lipopolysaccharides-treated human neutrophils. However, PDX has no effect on the 5-lipoxygenase pathway that produces the chemotactic agent leukotriene B4 (LTB4). Taken together, our results suggest that PDX could be a protective agent against neutrophil invasion in chronic inflammatory diseases.
Type de document :
Article dans une revue
Lipids, Springer Verlag, 2014, 49 (1), pp.49-57. 〈10.1007/s11745-013-3863-6〉
Liste complète des métadonnées

Littérature citée [14 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00909219
Contributeur : Evelyne Vericel <>
Soumis le : mardi 26 novembre 2013 - 09:41:47
Dernière modification le : mardi 17 juillet 2018 - 15:50:08
Document(s) archivé(s) le : samedi 8 avril 2017 - 02:21:35

Fichier

Lipids_last_version.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Miao Liu, Tarek Boussetta, Karama Makni-Maalej, Michèle Fay, Fathi Driss, et al.. Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities.. Lipids, Springer Verlag, 2014, 49 (1), pp.49-57. 〈10.1007/s11745-013-3863-6〉. 〈inserm-00909219〉

Partager

Métriques

Consultations de la notice

888

Téléchargements de fichiers

113